Tharimmune, Inc. | Finanzwire

Basculer en Français

9473	Companies
185399	Keywords
117755	Articles
99281	Press releases

Home
Companies
Tharimmune, Inc.

BRIEF

published on 07/22/2024 at 14:35, 1 year 4 months ago

Tharimmune Appoints Prof. David Jones of Newcastle University to its Scientific Advisory Board

Scientific Advisory Board TH104 Tharimmune David Jones Autoimmune Liver Disease
PRESS RELEASE

published on 07/22/2024 at 14:30, 1 year 4 months ago

Tharimmune Appoints Prof. David Jones of Newcastle University to its Scientific Advisory Board
Tharimmune, Inc. appoints Prof. David Jones, an expert in autoimmune liver disease, to its Scientific Advisory Board. Prof. Jones brings valuable insights to advance lead drug candidate TH104 for PBC patients

Scientific Advisory Board TH104 Tharimmune David Jones Autoimmune Liver Disease
BRIEF

published on 07/17/2024 at 14:35, 1 year 4 months ago

Tharimmune Appoints Global Business Executive David H. Clarke as Key Strategic Advisor

Biotechnology Strategic Advisor Tharimmune David H. Clarke
PRESS RELEASE

published on 07/17/2024 at 14:30, 1 year 4 months ago

Tharimmune Appoints Global Business Executive David H. Clarke as Key Strategic Advisor
Tharimmune, Inc. appoints David H. Clarke as Strategic Advisor, bringing valuable experience to enhance company's leadership and growth in inflammation and immunology therapeutics

Biotechnology Appointment Tharimmune Inc. Inflammation David H. Clarke
BRIEF

published on 07/10/2024 at 14:35, 1 year 4 months ago

Tharimmune Appoints Jules Haimovitz as Key Strategic Advisor

Biotechnology Strategic Advisor Tharimmune Jules Haimovitz Phase 2 Program
PRESS RELEASE

published on 07/10/2024 at 14:30, 1 year 4 months ago

Tharimmune Appoints Jules Haimovitz as Key Strategic Advisor
Tharimmune, Inc. appoints Jules Haimovitz as Strategic Advisor, leveraging his biotechnology leadership and experience. The move enhances Tharimmune's clinical programs and FDA Phase 2 progress

Biotechnology Tharimmune Inc. Clinical Programs Jules Haimovitz FDA Phase 2
BRIEF

published on 06/17/2024 at 14:05, 1 year 5 months ago

Tharimmune Announces Positive Type C Meeting with FDA for Phase 2 Program for TH104

FDA TH104 Phase 2 Trial Tharimmune PBC
PRESS RELEASE

published on 06/17/2024 at 14:00, 1 year 5 months ago

Tharimmune Announces Positive Type C Meeting with FDA for Phase 2 Program for TH104, its Lead Candidate for Moderate-to-Severe Pruritus in Primary Biliary Cholangitis
Tharimmune, Inc. receives positive FDA Type C meeting feedback for TH104 Phase 2 program, targeting pruritus in PBC patients, plans 505(b)(2) pathway for approval

FDA Feedback Tharimmune Inc TH104 Phase 2 Pruritus PBC Patients
BRIEF

published on 04/30/2024 at 14:36, 1 year 7 months ago

Tharimmune to Engage Investors at Two Major Conferences in May

Biotechnology Investor Conferences Investor Engagement Tharimmune Inflammation And Immunology
PRESS RELEASE

published on 04/30/2024 at 14:31, 1 year 7 months ago

Tharimmune To Participate in Two Upcoming Investor Conferences in May
Tharimmune to present at investor conferences in May 2024, showcasing developments in inflammation & immunology therapies. CEO to participate in Planet MicroCap Showcase: VEGAS 2024 & EF Hutton Annual Global Conference

Investor Conferences Tharimmune Inflammation Immunology Therapeutic Candidates

Accesswire

Published on 12/05/2025 at 02:35, 6 hours 23 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 6 hours 28 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 58 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 53 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 58 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:30, 27 minutes ago

Dahua Technology Celebrates Pro Challenge 2025 to Deepen Global Installer Ecosystem Collaboration
Published on 12/05/2025 at 08:30, 28 minutes ago

Premier Miton Global Renewables Trust PLC - Suspension
Published on 12/05/2025 at 08:05, 52 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 57 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 57 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025

Les Echos

Published on 12/05/2025 at 08:45, 13 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 14 hours 58 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 15 hours 13 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 15 hours 13 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE